Kwality Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Kwality Pharma	Indoco Remedies	Ind-Swift Lab.
Operational Metrics
Financials
5 yr Average ROE	25.27 %	10.38 %	14.7 %
5yr average Equity Multiplier	1.96	1.9	2.17
5yr Average Asset Turnover Ratio	1.05	0.88	0.66
5yr Avg Net Profit Margin	11.66 %	5.41 %	16.17 %
Price to Book	5.21	1.74	0.91
P/E	26.73	0.0	4.77
5yr Avg Cash Conversion Cycle	55.02 Days	35.3 Days	15.71 Days
Inventory Days	67.04 Days	70.6 Days	103.91 Days
Days Receivable	132.46 Days	83.16 Days	105.66 Days
Days Payable	126.93 Days	111.01 Days	107.02 Days
5yr Average Interest Coverage Ratio	16.13	7.53	21.19
5yr Avg ROCE	34.73 %	13.6 %	12.09 %
5yr Avg Operating Profit Margin	23.23 %	14.97 %	14.94 %
5 yr average Debt to Equity	0.46	0.49	0.91
5yr CAGR Net Profit	21.34 %	n/a	n/a
5yr Average Return on Assets	12.96 %	5.31 %	11.49 %
Shareholdings
Promoter Holding	54.83 %	58.9 %	39.5 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.38 %	0.21 %	-2.5 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.27 %	0.0

	Kwality Pharma	Indoco Remedies	Ind-Swift Lab.
Segment Break-Up	Segment Break-Up Formulations 100.0	-	-
Formulations Breakup	Formulations Breakup Others 100	-	-
Location Wise Break-Up	Location Wise Break-Up India 47.21 Rest of the World 0 Others 52.79	Location Wise Break-Up Rest of the World 35.63 India 64.37	Location Wise Break-Up Rest of the World 0 India 27.72 Others 72.28